ArticleJournal of robotic surgery2026
Biological surgical stress after minimally invasive lung resection for non-small cell lung cancer: comparing robotic and thoracoscopic surgical platforms.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In resectable non-small cell lung cancer (NSCLC), a minimally invasive surgical approach is considered standard. Robotic-assisted thoracic surgery (RATS) and video-assisted thoracoscopic surgery (VATS) are two such approaches that have demonstrated comparable clinical outcomes on conventional postoperative endpoints. Potential differences in perioperative biological surgical stress remain incompletely characterized. Acute-phase inflammatory biomarkers may provide objective insight beyond conventional postoperative endpoints. We performed a single-center retrospective cohort study of patients with NSCLC undergoing minimally invasive pulmonary resection. Paired preoperative and early postoperative (48 h) inflammatory markers were analyzed. The primary endpoints were perioperative changes in C-reactive protein (CRP) and in the CRP-to-albumin ratio (CAR). Secondary endpoints included postoperative complications, persistent air leak, and hospital length of stay (LOS). Associations between changes in inflammatory markers and clinical outcomes were evaluated using multivariable analyses. A total of 137 patients were included, with complete paired inflammatory data available for 112 patients (RATS n = 52; VATS n = 60). Patients who underwent RATS had significantly smaller postoperative increases in CRP and CAR than patients who underwent VATS (median ΔCRP: 2.79 vs. 4.99 mg/dL, p = 0.005; median ΔCAR: 0.64 vs. 1.11, p = 0.004). This occurred despite significantly greater intraoperative blood loss, longer surgical time, and a higher incidence of systematic lymphadenectomy in the RATS group. These associations remained significant, and their magnitude increased, after adjustment for intraoperative blood loss, surgical time, and number of dissected lymph nodes, and persisted in a sensitivity analysis restricted to anatomical resections. Surgical approach was not independently associated with postoperative complications or LOS, but greater perioperative increases in CRP and CAR were significantly associated with prolonged LOS. The early postoperative acute-phase inflammatory response was significantly less pronounced following RATS than VATS, independently of measured indicators of surgical invasiveness and despite more extensive lymphadenectomy in the RATS group. Perioperative trajectories of CRP-based indices, particularly CAR, may serve as sensitive markers of biological surgical stress beyond conventional clinical endpoints.
Indexed as
Identifiers
42758414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.